India's generics makers hire Beltway help

Share this article:

India's generic drugmakers are not going to take it anymore. BusinessWorld reports that the Indian Pharmaceutical Alliance has hired the Washington, DC, strategy group India First LLC to promote the value of the country's generic drugs.

India First said in a statement that it will take on Big Pharma lobbying forces, such as PhRMA and the National Association of Manufacturers which “downgrade the reputation of Indian pharmaceuticals in order to maintain marketshare and destroy competition.”

India's generics industry can be lightly described as troubled. The US has banned drugs from four Ranbaxy pharmaceutical sites over manufacturing site integrity. Parent company Sun Pharmaceuticals has been similarly pinched, for reasons including file destruction and hiding unfavorable data.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Social media perceived as clinical trial risk

The Wall Street Journal reports that patients are sharing a plethora of information about their clinical trial experiences, from how to get picked, to how to figure out who is in a control group.

Cancer PSA features scientists

Stand Up To Cancer is kicking off a PSA that features Grammy-winner Jennifer Hudson and a Genentech scientist.

Lawmakers eye pricing

The Senate Judiciary Committee's antitrust panel is looking into how three major pharmaceutical manufacturers decided to set minimum prices for their contact lenses.